Home › SEC Filings › Press Releases
Press Releases
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| MU | PRESS-RELEASE | neutral | 2/10 | Micron announced a technology webinar on Oct. 21, 2026, where its president and CTO will discuss the company's memory an | Oct 19, 2026 |
| DFDV | PRESS-RELEASE | neutral | 3/10 | DeFi Development Corp. announced its SOL treasury grew by 3,983 SOL to ~2,590,266 SOL, and increased the annual dividend | Oct 19, 2026 |
| SNES | PRESS-RELEASE | neutral | 4/10 | SenesTech announced results from a Chicago pilot showing an 88% reduction in rat activity intensity using Evolve Rat Bir | Oct 19, 2026 |
| URGN | PRESS-RELEASE | bullish | 6/10 | UroGen Pharma announced FDA acceptance of its NDA for UGN-103 (mitomycin) for recurrent low-grade intermediate-risk non- | Oct 19, 2026 |
| BIVI | PRESS-RELEASE | neutral | 5/10 | BioVie presented Phase 2 ADDRESS-LC data for bezisterim in Long COVID at ANA 2026. The trial did not achieve statistical | Oct 19, 2026 |
| CLNN | PRESS-RELEASE | bullish | 8/10 | Clene Inc. announced it has submitted a New Drug Application (NDA) to the FDA seeking accelerated approval of CNM-Au8 fo | Oct 19, 2026 |
| STM | PRESS-RELEASE | neutral | 2/10 | STMicroelectronics disclosed a routine weekly share repurchase of 492,285 shares (0.05% of issued capital) for EUR 21.1 | Oct 19, 2026 |
| RDHL | PRESS-RELEASE | neutral | 3/10 | RedHill's partner, the University of Oklahoma, received a $2.9 million NCI grant to fund Phase 1b/2 clinical trials of o | Oct 19, 2026 |
| GLNG | PRESS-RELEASE | neutral | 1/10 | Golar LNG announced it will host a conference call on November 18, 2026 to discuss its Q3 2026 results. | Oct 19, 2026 |
| ATH-PA | PRESS-RELEASE | neutral | 1/10 | Athene Holding Ltd. announced it will host a conference call to discuss its Q3 2026 results. | Oct 19, 2026 |
| CHRD | PRESS-RELEASE | bullish | 6/10 | Chord Energy reported preliminary Q3 2026 results with volumes exceeding the high end of guidance across all products an | Oct 19, 2026 |
| BWAY | PRESS-RELEASE | neutral | 4/10 | BrainsWay announced a strategic collaboration with Inland Psychiatric Medical Group (IPMG), including a multisystem orde | Oct 19, 2026 |
| GLAS | PRESS-RELEASE | mixed | 5/10 | Glass House Brands reported preliminary Q3 2026 revenue of $56.8M (up 117% YoY from $26.2M) and record biomass productio | Oct 19, 2026 |
| BIIB | PRESS-RELEASE | neutral | 4/10 | Biogen is presenting new 76-week EMPAVELI data at ASN Kidney Week showing sustained proteinuria reduction and continued | Oct 19, 2026 |
| CRMD | PRESS-RELEASE | bullish | 7/10 | CorMedix announced FDA acceptance of its sNDA for REZZAYO (rezafungin) for prophylaxis of invasive fungal disease, with | Oct 19, 2026 |
| REKR | PRESS-RELEASE | bearish | 5/10 | Rekor Systems filed a lawsuit in Delaware Chancery Court against a former board member for alleged fiduciary duty breach | Oct 19, 2026 |
| CHRD | PRESS-RELEASE | neutral | 3/10 | Chord Energy announced that Michael Lou has been appointed President & CEO, effective immediately, succeeding Danny Brow | Oct 19, 2026 |
| CDNL | PRESS-RELEASE | bullish | 5/10 | Cardinal Infrastructure Group amended its agreement to acquire Hughes Brothers Construction, keeping the $357.5 million | Oct 19, 2026 |
| GL | PRESS-RELEASE | neutral | 1/10 | Globe Life Inc. announced it will report its Q3 2026 results on October 21, 2026. | Oct 19, 2026 |
| SHLS | PRESS-RELEASE | neutral | 1/10 | Shoals Technologies Group announced it will report its Q3 2026 results on November 4. | Oct 19, 2026 |
| HOS | PRESS-RELEASE | neutral | 1/10 | Hornbeck Offshore Services, Inc. announced it will report its Q3 2026 results. | Oct 19, 2026 |
| TNXP | PRESS-RELEASE | neutral | 3/10 | Tonix Pharmaceuticals announced a poster presentation on TONMYA (cyclobenzaprine HCl sublingual tablets) for fibromyalgi | Oct 19, 2026 |
| EYPT | PRESS-RELEASE | bearish | 7/10 | EyePoint announced that its second Phase 3 trial (LUCIA) of DURAVYU in wet AMD failed to meet the primary endpoint of no | Oct 19, 2026 |
| IRON | PRESS-RELEASE | bullish | 8/10 | Disc Medicine announced overwhelmingly positive topline results from the APOLLO Phase 3 trial of bitopertin in erythropo | Oct 19, 2026 |
| ATYR | PRESS-RELEASE | neutral | 3/10 | aTyr Pharma announced a research collaboration with Albert Einstein College of Medicine to further develop ATYR2810, its | Oct 19, 2026 |
| MRKR | PRESS-RELEASE | bullish | 5/10 | Marker Therapeutics received a $2.6 million FDA Orphan Products Clinical Trials grant to support a Phase 1 study of its | Oct 19, 2026 |
| PBLS | PRESS-RELEASE | neutral | 4/10 | Parabilis Medicines announced an upcoming oral presentation at ESMO 2026 of updated Phase 1/2 data for zolucatetide in d | Oct 19, 2026 |
| PTC | PRESS-RELEASE | bullish | 7/10 | PTC announced it will release fiscal Q4 and full-year 2026 results on November 4th after market close, and reiterated it | Oct 19, 2026 |
| VAI | PRESS-RELEASE | neutral | 4/10 | Valor Energy Inc. (VAI) announced an agreement to acquire an 18MW operational computing center in Youngstown, Ohio for $ | Oct 19, 2026 |
| BRSL | PRESS-RELEASE | neutral | 1/10 | Brightstar Lottery PLC announced it will host a conference call on November 10, 2026 to discuss its Q3 2026 results. | Oct 19, 2026 |